Effect of Inspiratory Muscle Training on Knee Osteoarthritis Pain
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
Knee osteoarthritis (KOA) is a common joint disease that causes chronic pain and limits daily activities. Current treatments, such as painkillers or surgery, have limitations like side effects or high costs. This study will test whether a safe, non-drug intervention-inspiratory muscle training (breathing exercises against resistance)-can reduce knee pain in people with KOA. The training may work by lowering inflammation and improving the brain's modulation of pain. Eighty patients aged ≥55 years with confirmed KOA and frequent knee pain will be enrolled. Participants will be randomly assigned to either an 8-week inspiratory muscle training program (5 sessions per week, with gradually increasing resistance) or a sham (very low resistance) training program. Neither the patients nor the researchers assessing the outcomes will know who is in which group. The main outcome is change in knee pain measured by a visual analog scale (VAS). Secondary outcomes include blood markers of inflammation (TNF-α, IL-6, IL1β), physical function, the Knee injury and Osteoarthritis Outcome Score (KOOS), inspiratory muscle strength, activity level, sleep quality, and quality of life. To explore underlying mechanisms, outcomes included heart rate variability (HRV) as an indicator of autonomic nervous system function, and brain functional connectivity in the prefrontal cortex using functional near-infrared spectroscopy (fNIRS) are collected. These mechanistic assessments will be performed at baseline and at the end of 8-week intervention. Additional follow-up assessments for clinical outcomes will be done at 3 and 6 months after the training ends. Any side effects or adverse events will be recorded. This study will provide high-quality evidence on whether inspiratory muscle training is an effective and safe complementary treatment for knee pain in people with knee OA, and will offer new insights into the mechanisms underlying its analgesic effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Sep 2026
Longer than P75 for not_applicable knee-osteoarthritis
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2030
Study Completion
Last participant's last visit for all outcomes
September 1, 2030
July 16, 2026
April 1, 2026
4 years
July 7, 2026
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analogue scale
Self-rated pain intensity of knee (0-100), "0" indicate no pain, "100" indicate worst pain.
Baseline, week 8, 3-month after intervention, 6-month after intervention
Secondary Outcomes (10)
The Knee injury and Osteoarthritis Outcome Score
Baseline, week 8, 3-month after intervention, 6-month after intervention
Serum levels of inflammatory markers
Baseline, up to week 8
Heart rate variability
Baseline, up to week 8
Prefrontal cortex activity
Baseline, up to week 8
40-meter walk test
Baseline, up to week 8
- +5 more secondary outcomes
Other Outcomes (2)
Adherence
Up to week 8
Adverse events
Up to week 8
Study Arms (2)
Inspiratory Muscle Training
EXPERIMENTAL5 sessions/week for 8 weeks. Load starts at 50% MIP for 40 reps, increases to 80% MIP for 60 reps from week 5, then adjusted weekly to 80% of updated MIP. Device: threshold inspiratory muscle trainer.
Sham Inspiratory Muscle Training
SHAM COMPARATORParticipants perform sham inspiratory muscle training with the same frequency and duration as the experimental group, but the inspiratory load is fixed at 10% of maximal inspiratory pressure (MIP) and does not progress. All other procedures (weekly MIP measurement for sham load adjustment) are identical to maintain blinding.
Interventions
Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus). Training is conducted 5 times per week for 8 weeks. The initial inspiratory load is set at 50% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site. The load is progressively increased to 80% MIP over the first 4 weeks and maintained at 80% MIP for the remaining 4 weeks. Each session consists of 40-60 breaths. Adherence is monitored via an electronic training log and weekly on-site visits. This protocol is individualized, progressive, and home-based, distinguishing it from fixed-load or supervised-only breathing interventions.
Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus). Training is conducted 5 times per week for 8 weeks. The initial inspiratory load is set at 10% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site. The load is maintained 10% MIP over 8 weeks. Each session consists of 40-60 breaths. Adherence is monitored via an electronic training log and weekly on-site visits.
Eligibility Criteria
You may qualify if:
- Aged 55 years or older.
- Knee osteoarthritis (Kellgren-Lawrence grade ≥ 2).
- Knee pain (Visual Analogue Scale, VAS ≥ 3) on the most days in the past month.
- Able to walk independently without assitive devices.
You may not qualify if:
- History of knee replacement surgery, meniscus surgery, or ligament surgery.
- Received corticosteroid injection within the previous three weeks.
- Diagnosed with rheumatoid arthritis.
- Unstable angina, recent myocardial infarction, uncontrolled cardiac arrhythmia, or severe heart failure.
- History of stroke.
- Currently receiving steroid therapy, hormonal therapy, or cancer chemotherapy.
- Pneumothorax, pulmonary bullae, lung surgery within the past 12 months, unstable asthma, or severe dyspnea at rest.
- Unable to understand the study procedures and potential risks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hong Kong Polytechnic Universitylead
- Zunyi Medical Collegecollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants, outcome assessors, and data analyst are blinded. Care provider is not blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
July 7, 2026
First Posted
July 13, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2030
Study Completion (Estimated)
September 1, 2030
Last Updated
July 16, 2026
Record last verified: 2026-04